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Abstract
Background: To analyze blood loss after delivery in women with induction of labor compared to women with
spontaneous onset of labor.
Methods: In this secondary analysis of a prospective cohort study investigating postpartum hemorrhage, 965
deliveries were analyzed including 380 women with induction of labor (39%) between 2015 and 2016. Primary
outcome parameters were rate of postpartum hemorrhage, estimated blood loss and post-partum decrease in
hemoglobin.
Results: Rates of postpartum hemorrhage and estimated blood loss were not significantly different in women with
induction of labor. Women with induction of labor had a significantly reduced decrease in hemoglobin after
delivery. In the multivariate linear regression analysis, induction of labor remained associated with reduced decrease
in hemoglobin. Secondary maternal and neonatal outcomes were unaffected.
Conclusions: Induction of labor is not associated with increased blood loss after delivery and should not be
regarded as a risk factor for postpartum hemorrhage.
Keywords: Induction of labor, Spontaneous onset of labor, Postpartum hemorrhage, Postpartum blood loss, Delta
hemoglobin
Background
Postpartum Hemorrhage (PPH) is defined by the WHO as
blood loss of 500ml or more within 24 h after birth [1].
Another, less commonly used definition distinguishes va-
ginal deliveries (blood loss > 500ml) from cesarean sec-
tions (> 1000ml) [2]. PPH affects approximately 2% of all
women giving birth and remains a leading cause of mater-
nal morbidity (blood transfusion, maternal admission to
an intensive care unit [ICU], hysterectomy) and mortality.
Maternal death due to PPH occurs in 1/1000 deliveries in
developing countries and in 1/100000 deliveries in high-
income countries such as the U.K. [3, 4].
Currently, average rates of induction of labor (IOL)
based on international studies are approximately 20–25%
of all pregnancies [5, 6]. Aside from medical reasons, IOL
upon maternal request is a common procedure [7].
The risk for PPH following IOL has been published
with partially conflicting results, even though many of
the studies suggested that IOL would be associated with
PPH. However, the majority of available studies were not
designed to analyze the effect of IOL on blood loss fol-
lowing delivery [8–19] due to an imperfect analysis of
other important risk factors for increased blood loss
after delivery. Furthermore, none of the studies so far
analyzed the correlation between IOL and linear vari-
ables of blood loss such as estimated blood loss (EBL) or
post-partum decrease in hemoglobin (ΔHb), even less so
in a multivariate analysis.
The objective of our study was to analyze blood loss in
women with IOL compared to women with spontaneous
onset of labor (SOL). Blood loss was assessed by rate of
PPH, EBL (mL), and ΔHb (in g/l). Secondary outcome
parameters included maternal and neonatal outcome
after IOL.
Methods
This was a secondary subgroup analysis of a prospective
cohort study investigating risk factors for PPH at Uni-
versity Hospital Zurich, a tertiary care perinatal center,
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between October 2015 and November 2016 (PPH-study,
ClinicalTrials.govID: NCT02604602). The study has eth-
ical approval according to the ethics review board of
Zurich (reference number KEK-ZH 2015–0011, date of
approval: 4.9.2015).
Data were collected prospectively and recorded imme-
diately after the delivery by the midwife and the attend-
ing physician in our electronic database which contains
all the patients’ diagnoses and prospectively collected
clinical data on the course of the pregnancy, delivery as
well as maternal and infant outcome. A staff of three
trained research personnel extracted the collected data
prospectively into the study database using three clinical
informatics systems: IntelliSpace Perinatal (OB TraceVue
[OBTV], https://www.usa.philips.com), Perinat, and
KISIM (both University Hospital Zurich products). The
data was double-checked by the principal investigators
and in case of dubious values the patient’s charts were
studied again.
Inclusion criteria were planned vaginal delivery,
written patient consent, singleton gestation, > 36 + 0
weeks of gestation and vertex position. Exclusion cri-
teria were breech position, elective cesarean section,
placenta previa, multiple fetus pregnancies and known
coagulation disorders. Eligible patients were included
consecutively into the prospective study. In total, 965
out of the 1500 patients of the primary study fulfilled
the inclusion criteria, including 380 women with IOL
(39.4%) and 585 (60.6%) women with SOL. Being a
secondary subgroup analysis, a sample size calculation
was not performed.
Primary outcomes were the rate of PPH defined as
blood loss of ≥500 ml after spontaneous delivery and ≥
1000 ml after cesarean section within 24 h of delivery,
estimated blood loss (EBL), ΔHb and rate of ΔHb ≥
30 g/l. ΔHb ≥30 g/l was arbitrarily considered as clin-
ically significant. In spontaneous deliveries, EBL is
measured with a quantitative method in our institu-
tion. Immediately after delivery of the baby, a new
pad was placed underneath the woman’s pelvis. In
case of suspected increased bleeding, these pads were
weighed on a neonatal scale which was present in
every delivery room. If weighed blood loss exceeded
300 ml, a collector bag with a quantitative scale was
installed under the woman’s pelvis. Blood loss was
documented regularly until the removal of the collector
bag, which was performed after successful treatment of
PPH and normalized bleeding intensity. The overall EBL
within 24 h after delivery was modified if a possible in-
creased blood loss after removal of the collector bag oc-
curred by weighing these pads again. This method of
blood loss measurement enabled reliable blood loss esti-
mation, as has been shown previously [20]. In our institu-
tion, determination of Hb level is performed routinely
prepartum as well as 24 to 48 h postpartum for all parturi-
ent women. Every value of hemoglobin was inserted and
interpreted individually in our prospective database. In
women with increased blood loss, several blood tests are
likely to be performed and trained research personnel are
essential to choose the appropriate hemoglobin value
since hemoglobin concentration immediately after bleed-
ing will be measured falsely high due to still outstanding
auto-transfusion and hemoglobin concentration immedi-
ately after intensive fluid replacement therapy will be
quantified falsely low [20]. Usually the clinically most rea-
sonable hemoglobin value in women with increased bleed-
ing represents the level 48 h postpartum. Necessity of
blood transfusion was evaluated as well. In case of blood
transfusion, the hemoglobin level before the transfusion
was chosen.
In case of discrepancy between observed clinical
course and extracted EBL or ΔHb, the patient’s chart
was checked together with responsible physicians and
midwives.
Secondary outcome variables included mode of deliv-
ery (spontaneous vaginal delivery, operative vaginal de-
livery, and unplanned cesarean section), length of
hospital stay, need for surgical management due to PPH
(such as B-Lynch sutures or hysterectomy), and neonatal
outcome parameters (admission to neonatal care unit,
arterial umbilical cord pH, 5′ and 10′ Apgar score,
shoulder dystocia, and meconium staining of the amni-
otic fluid).
Furthermore, data on the following obstetric parame-
ters were collected: IOL, method and duration of induc-
tion, gestational age at delivery, parity, maternal age at
delivery, body mass index (BMI), duration of the first
and second stage of labor, type of anesthesia during
labor, uterus atony, retention of placenta or placental tis-
sue, placental abruption, morbidly adherent placenta
(placenta accreta, increta, and percreta), admission to in-
tensive care unit, uterine rupture, amnion infection, anal
sphincter tear, and infant birthweight.
Methods for IOL were oxytocin, misoprostol or both
(misoprostol followed by oxytocin). Misoprostol induc-
tion was conducted with 25 micrograms of vaginal miso-
prostol repeated after 4 h if no contractions were noted
up to a daily maximum dosage of 150 micrograms [21].
Oxytocin infusion via an infusion pump was initiated
with 0.002 IU/minute and increased until adequate uter-
ine activity (3–4 contractions/10 min) was obtained.
Women with previous cesarean sections did not receive
misoprostol.
Baseline as well as maternal and neonatal outcome pa-
rameters were compared between women with IOL and
SOL. Differences between groups were analyzed with the
Mann-Whitney U test for continuous variables and the
Chi- square test or the Fisher’s exact test for categorical
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variables as appropriate. A multivariate linear regres-
sion analysis was performed to evaluate the associ-
ation of the following variables on ΔHb: IOL,
prolonged duration of induction (> 48 h), maternal
BMI, gestational age, maternal age, repeat cesarean
section and unplanned cesarean section, multiparity,
duration of the second stage of labor > 2 h, retention
of placenta or placental tissue, fetal weight, placental
abruption, uterus atony.
All statistical analyses were performed using IBM SPSS
Statistics, version 22.0 (Armonk, NY: IBM Corp.). Due
to multiple testing and in order to avoid the multiple
comparisons problem which increases the probability of
a false positive finding, level of statistical significance
was set at p < 0.01.
Results
Baseline characteristics showed significant difference re-
garding maternal BMI, gestational age and birthweight
(Table 1).
As method of induction, 138 (36.3%) women received
oxytocin, 199 (52.4%) misoprostol and 43 (11.3%) miso-
prostol followed by oxytocin.
Incidence of PPH did not differ between women with
IOL compared to women with SOL (24.7% vs. 21.2%,
p = 0.20). This was also the case when using the PPH-
definition proposed by the WHO (PPH defined as a
blood loss of 500 ml or more within 24 h after birth, irre-
spective of the mode of delivery) [1]. Likewise, rates of
EBL ≥1000ml or ≥ 1500ml did not differ between
groups. The estimated blood loss was comparable in the
IOL group (median 400 [300–600] ml vs 400 [300–500]
ml, p = 0.03) while ΔHb was significantly lower in
women with IOL (median 13 [5–21] g/l vs 16 [9.0–24]
g/l, p < 0.01). ΔHb > 30 g/l was not significantly different
in study group vs. controls (12.9% vs. 13.8%, p = 0.67).
Rates of vaginal-operative delivery and unplanned
cesarean section as well as length of hospital stay were
not different.
All secondary neonatal outcome parameters were
comparable between both groups. Maternal and neo-
natal outcome data is shown in Table 2. None of our
patients needed surgery to treat PPH (B-Lynch sutures
or hysterectomy).
In a multivariable linear regression analysis, IOL was in-
dependently associated with reduced ΔHb (− 3.4 g/l [CI
95% -4.98 to − 1.79], p < 0.001). Other factors that had a
statistically significant impact on ΔHb were multiparity,
second stage of labor > 120min, uterine atony, retention
of placenta and placental tissue (Table 3). Prolonged IOL
(> 48 h) was not associated with increased blood loss in
the multivariable regression analysis.
Discussion
This secondary analysis of a prospective study tested for
the impact of IOL on postpartum blood loss. To our
best knowledge, this is the first study to analyze pro-
spectively collected data about blood loss after IOL as
primary outcome parameter with adjustment for import-
ant risk factors of PPH.
We showed that IOL is not associated with increased
blood loss after delivery. IOL was even associated with a
slight, however statistically significant, reduced decrease
in hemoglobin after delivery compared to SOL. This
finding remained statistically significant in the multivari-
able linear regression analysis. According to this only
slightly reduced decrease in hemoglobin after IOL, a
clinical relevant loss of hemoglobin defined as ΔHb ≥30
g/l was not different in women with IOL as compared to
women with SOL.
Our findings are in accordance with a recent Cochrane
Review [22], which assessed the outcome of IOL in
women at or beyond term (i.e., from 37 completed
weeks of pregnancy). With regard to PPH, four pub-
lished randomized controlled trials and one abstract
were included with no evidence of a difference between
IOL and SOL (RR 1.09 95%CI 0.92 to 1.30, low-quality
evidence). However, all of these trials were primarily de-
signed to evaluate the mode of delivery (cesarean rate)
[23–25] or neonatal outcome [26] but not postpartum
blood loss. Hence, there was no information about im-
portant causes for PPH such as uterine atony, retained
placenta, increased bleeding from lacerations or coagu-
lopathy. Furthermore, analysis of decrease in
hemoglobin after delivery as an objective parameter for
blood loss was not performed in any of these studies.
In contrast to the above mentioned trials and to our
findings, eight of nine retrospective studies [8–10, 12,
13, 15–17, 27] that examined IOL as a possible risk fac-
tor for PPH, found IOL to be associated with the occur-
rence of PPH [8–10, 13, 15–17, 27].
Reported odds ratios for blood loss > 500 mL after
IOL ranged from 1.4 to 4.1 [8, 9, 15, 27] and those for
blood loss > 1500 mL were 1.6 [17]. However, there are
important methodological issues to discuss in these
analyses. In seven of these nine studies, no adequate
Table 1 Baseline Characteristics
Characteristics IOL (n = 380) SOL (n = 585) p
Multiparity 155 (40.8%) 270 (46.2%) 0.101a
BMI (kg/m2) 24.9 ± 4.8 23.8 ± 4.5 < 0.001b
Age in years 32.2 ± 5 32.4 ± 4.8 0.51b
Gestational age in days 280 ± 9.1 277 ± 8.4 < 0.001b
Birthweight in g 3440 (3130–3739) 3340 (3065–3613) < 0.01b
Data presented as n (%), mean ± SD or median (25th percentile – 75th
percentile) as appropriate. n number, SD standard deviation, a: Chi square Test,
b: Mann Whitney U Test
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multivariate analysis for the above mentioned acknowl-
edged risk factors for PPH was performed [8–10, 12,
13, 15, 16]. Furthermore, decrease in hemoglobin after
delivery was analyzed in only one study [13], in which
no multivariate analysis was performed. Finally and
most importantly, five studies [8, 15–17, 27] were not
designed to analyze IOL and its impact on PPH, but ra-
ther studied women with PPH and retrospectively
looked at possible risk factors for PPH. Albeit these
studies are undoubtedly of importance to anticipate
prospective studies, they are of low value to discuss a
single risk factor such as IOL alone as comparison of
patients subgroups (with or without IOL) isn’t feasible.
A secondary analysis of a large French trial, which ana-
lyzed the effect of a multifaceted intervention on the re-
duction of severe PPH, assessed the association between
IOL and PPH in low-risk parturients [19]. It sug-
gested that only women with IOL following a stand-
ard indication were at higher risk of PPH (adjusted
OR 1.22, 95%CI 1.04–1.42), however not of severe
PPH. Besides having substantial strengths such as in-
clusion of a large number of women (n = 6′621) and
detailed information about the mode of IOL as well
as the cervical status, the study showed limitations
that might have contributed to the heterogeneous re-
sults. For instance, the main obstetrical reasons for
Table 2 Maternal and neonatal outcome
Blood loss parameters Women with IOL (n = 380) Women with SOL (n = 585) p
Estimated blood loss (mL) 400 (300–600) 400 (300–500) 0.03 a
Estimated blood loss ≥500mL 152 (40%) 195 (33.3%) 0.03 b
Estimated blood loss ≥1000mL 24 (6.3%) 37 (6.3%) 1.00 b
Estimated blood loss ≥1500mL 9 (2.4%) 10 (1.7%) 0.47 b
Postpartum Hemorrhage 94 (24.7%) 124 (21.2%) 0.20 b
Delta hemoglobin (g/L) 13 (5–21) 16 (9.0–24.0) < 0.01 a
Delta hemoglobin ≥30 g/L 49 (12.9%) 81 (13.8%) 0.67 b
Blood transfusion 1 (0.3%) 0 (0.0%) 0.39 c
Secondary maternal outcome
Vaginal delivery 238 (62.6%) 390 (66.7%) 0.20 b
Operative vaginal delivery 51 (13.4%) 72 (12.3%) 0.61 b
Second stage of labor > 120min 93 (30.6%) 132 (26.7%) 0.23 b
Unplanned cesarean section 91 (24%) 123 (21.0%) 0.29 b
Maternal ICU admission 2 (0.5%) 0 (0.0%) 0.15 c
Uterine atony 28 (7.4%) 25 (4.3%) 0.04 b
Retained placenta 10 (2.6%) 16 (2.7%) 0.92 b
Retained placental tissue 15 (3.9%) 13 (2.2%) 0.12 b
Placental abruption 1 (0.3%) 5 (0.9%) 0.41 c
Uterine rupture 1 (0.3%) 2 (0.3%) 1.0 c
Length of hospital stay after delivery 4 (3–4) 4 (3–4) 0.07 a
Anal sphincter tear 6 (1.6%) 4 (0.7%) 0.20 c
Secondary Neonatal outcome
Chorioamnionitis 5 (1.3%) 3 (0.5%) 0.28 c
Shoulder dystocia 7 (1.8%) 10 (1.7%) 0.88 b
Meconium staining 70 (18.4%) 107 (18.3%) 0.96 b
Umbilical arterial pH < 7.1 5 (1.3%) 11 (1.9%) 0.50 b
5′ Apgar score < 7 4 (1.1%) 6 (1.0%) 1.0 c
10′ Apgar score < 7 1 (0.3%) 0 (0%) 0.39 c
Admission to neonatal care unit 23 (6.1%) 16 (2.7%) 0.11 b
IOL induction of labor, SOL spontaneous onset of labor, Postpartum Hemorrhage: blood loss of ≥500ml after spontaneous delivery or ≥ 1000 ml after cesarean
section within 24 h of delivery
Data presented as n (%), or median (25th percentile – 75th percentile) as appropriate. n number, SD standard deviation; a: Mann Whitney U- Test, b Chi Square
Test, c: Fisher’s Exact test
Brun et al. BMC Pregnancy and Childbirth          (2019) 19:265 Page 4 of 7
increased postpartum blood loss, such as uterine
atony and retained placenta, were not included in the
analysis and no data about blood loss (in ml) or loss
of hemoglobin (in g/l) was reported.
To our knowledge, only one prospective study has
evaluated risk factors for PPH as a primary outcome
among approximately 11′300 South-American women,
showing IOL be one of them [18]. In this study by
Sosa et al., IOL was associated with severe PPH de-
fined as blood loss > 1000 mL (OR 2.0) but, interest-
ingly, not with PPH defined as blood loss > 500 mL.
However, as IOL was not the main focus of the study,
no information was given about patient characteristics
in the IOL and SOL groups. In addition, analysis of
ΔHb was not performed.
In conformity with recent, partly randomized con-
trolled studies [5, 11, 23–26] and in contrast to some
retrospective studies [9, 10, 12, 28], IOL was not as-
sociated with an increased risk for unplanned
cesarean section or operative vaginal delivery in our
study. The apparently high incidence of IOL in our
study population (39%) is explained by the study de-
sign, which excluded all patients with preterm deliver-
ies before 36 weeks of gestation. Unfortunately, our
study did not provide information about the medical
indication for IOL.
Multiparity was associated with a reduced decrease in
hemoglobin. Most of our multiparous patients had their
second or third delivery (67 and 24% respectively) leav-
ing only 11 patients with grand multiparity which is at
higher risk for complications. We think that in these
multiparous patients, blood loss is reduced due to faster
deliveries with a shorter second stage of laborEven
though our study is neither conducted nor designed for
analyzing other secondary outcomes such as length of
hospital stay, anal sphincter tears or neonatal outcome
parameters, we observed no difference between the IOL
and SOL groups.
A main strength of our study was its design as a
secondary subgroup analysis of a prospective PPH
study, thus guaranteeing thorough assessment of
blood loss parameters and risk factors. The calcula-
tion of ΔHb by measurement before and after delivery
poses an objective parameter to examine blood loss
during birth. Interpretation of hemoglobin values for
each study patient by trained research personnel, as
described above, is of absolute importance, especially
in women with increased blood loss requiring several
postpartum blood specimens. In vaginal deliveries,
estimated blood loss was determined by our plastic
bag system with a quantitative scale which enables a
reasonably precise measurement of blood loss. It is
generally accepted that without a quantitative meas-
urement method, blood loss is prone to underestima-
tion [29, 30].
Limitations of our study are the non-randomized
study design and the missing sample size calculation
which is impossible in secondary analysis. Hence, our
results need to be interpreted with caution. However,
in contrast to the existing randomized controlled tri-
als, our study design was developed to assess postpar-
tum blood loss with a focus on reliable analysis of
blood loss including decrease in hemoglobin after de-
livery. Another limitation is missing data about his-
tory of PPH, use of oxytocin for labor augmentation
during delivery and previous cesarean sections in our
patients. However, uterine rupture as the main reason
for increased blood loss in patients with previous
Table 3 Multivariable linear regression analysis for postpartum decrease in hemoglobin (ΔHb)
Influence on ΔHb (95% CI) in g/L Correlation coefficient p
Induction of labor −3.9 (−5.5 to −2.4) −0.15 < 0.001
BMI (kg/m2) 0.1 (−0.0 to 0.3) 0.05 0.09
Gestational age in days 0.0 (− 0.1 to 0.1) 0.01 0.83
Maternal age in years −0.1 (− 0.2 to 0.1) −0.33 0.26
Multiparity −6.1 (−7.7 to −4.4) −0.23 < 0.001
Second stage of labor > 120min 7.4 (5.6 to 9.3) 0.26 < 0.001
Retained placenta 15.7 (11.5 to19.9) 0.22 < 0.001
Retained placental tissue 11.9 (7.8 to 16.0 0.17 < 0.001
Birthweight in g 0.0 (−0.0 to 0.0) −0.02 0.66
Placental abruption 6.4 (−4.1 to 16.9) 0.04 0.24
Repeat cesarean section 7.8 (−0.8 to 16.4) 0.06 0.07
Unplanned cesarean section 2.7 (−0.6 to 6.1) 0.05 0.11
Uterine Atony 14.7 (11.5 to 17.9) 0.27 < 0.001
Induction of labor > 48 h 2.1 (−2.5 to 6.7) 0.03 0.36
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cesarean section was included in the analysis and did
not show any difference between groups.
Conclusions
IOL is not associated with increased blood loss after de-
livery. In fact, women with IOL show a statistically sig-
nificant reduced decrease in hemoglobin after delivery,
which is however clinically not relevant. Hence, IOL is a
safe procedure regarding PPH and cannot be regarded
as a risk factor for the incidence of PPH or increased
blood loss after delivery.
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